Howard D. Thames
Thames, Howard D.
Thames, Howard D., 19..-....
VIAF ID: 207517999 (Personal)
Permalink: http://viaf.org/viaf/207517999
Preferred Forms
- 100 0 _ ‡a Howard D. Thames
- 100 1 0 ‡a Thames, Howard D.
- 100 1 _ ‡a Thames, Howard D.
- 100 1 _ ‡a Thames, Howard D.
-
- 100 1 _ ‡a Thames, Howard D., ‡d 19..-....
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Fractionation in radiotherapy, 1987: | |
The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"? | |
An improved computer model for 60cobalt dose distributions | |
In regard to Solomon et al.: EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. IJROBP 2003;55:713-723 | |
Incidence and latency of radiation reactions | |
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups | |
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy | |
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer | |
Is the rate of repair of radiation-induced sublethal damage in rat spinal cord dependent on the size of dose per fraction? | |
Late radiation response of kidney assayed by tubule-cell survival | |
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model | |
Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study | |
The Limitations of Model-Based Experimental Design and Parameter Estimation in Sloppy Systems. | |
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG. | |
Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy | |
Metaanalyse klinischer Studien zur alleinigen Chemotherapie im Vergleich zur Kombination aus Chemotherapie plus Strahlentherapie bei der Behandlung des Morbus Hodgkin | |
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib | |
A new isoeffect curve for change in dose per fraction | |
A new method for computer generation of dose distributions from external x- and gamma-ray sources | |
New options in direct analysis of dose-response data | |
Optimal design of multifraction assays of colony survival in vivo. | |
The origins of translational radiation oncology - In memoriam H. Rodney Withers (21 September 1932-25 February 2015). | |
Overall treatment time and tumor control dose for head and neck tumors: The dog leg revisited | |
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy | |
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. | |
Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. | |
Predicting radiosensitivity using DNA end-binding complex analysis | |
Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining | |
Proliferation kinetics of a murine fibrosarcoma during fractionated irradiation | |
The proliferative response of mouse jejunal crypt cells to radiation-induced cell depletion is not mediated exclusively by transforming growth factor alpha | |
Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721 | |
Protection of mouse jejunal crypt cells by WR-2721 after small doses of radiation | |
Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice | |
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis | |
Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model | |
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations | |
Radiation response of the monkey kidney following contralateral nephrectomy | |
Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation. | |
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results | |
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British | |
Recovery from radiation damage in mouse lung: interpretation in terms of two rates of repair | |
Recovery from sublethal damage during fractionated irradiation of human FaDu SCC | |
Repair in mouse lung between multiple small doses of X rays | |
Repair rate in mouse lung after clinically relevant radiation doses per fraction | |
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours | |
Residual γH2AX foci predict local tumour control after radiotherapy. | |
The response of Chinese hamster ovary cells to fast neutron radiotherapy beams. III. Variation in biological effectiveness with position in the cell cycle | |
Response of fibrosarcoma cell subpopulations to small doses of radiation delivered in situ | |
Response of plateau-phase C3H 10T1/2 cells to radiation and concurrent administration of bleomycin | |
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma | |
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy | |
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. | |
Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment | |
State-vector models of the cell cycle. 1. Parametrization and fits to labeled mitoses data | |
Survival of mouse testicular stem cells after gamma of neutron irradiation | |
Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation | |
A Test for Dose-Modifying Factors | |
Test of equal effect per fraction and estimation of initial clonogen number in microcolony assays of survival after fractionated irradiation | |
Time-dose considerations for normal-tissue tolerance | |
Time-dose factors in radiotherapy: a review of the human data. | |
Time factor for tonsillar carcinoma | |
Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. | |
The translational research chain: is it delivering the goods? | |
Tumor radioresistance in clinical radiotherapy | |
Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range | |
Tumor volume and local control probability: clinical data and radiobiological interpretations | |
Twice-daily fractionation schemes for advanced head and neck cancer | |
Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses | |
Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation | |
Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value? | |
The Withers archive: Online availability of rod Wither's data. | |
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era | |
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material. |